These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2950624)

  • 1. Prevention of graft-versus-host disease by natural suppressor cells.
    Hertel-Wulff B; Palathumpat V; Schwadron R; Strober S
    Transplant Proc; 1987 Feb; 19(1 Pt 1):536-9. PubMed ID: 2950624
    [No Abstract]   [Full Text] [Related]  

  • 2. [Suppressor action of the liver in the graft vs. host reaction].
    Divanian Kh
    Eksp Med Morfol; 1985; 24(2):25-30. PubMed ID: 2933241
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease.
    Via CS; Sharrow SO; Shearer GM
    J Immunol; 1987 Sep; 139(6):1840-9. PubMed ID: 2957440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The host response in graft versus host disease. III. The in vitro induction of regulatory cells in chronic murine graft versus host disease.
    Mann RA; Singh AB; Jetzt AE; Singh M
    Cell Immunol; 1995 Aug; 164(1):1-10. PubMed ID: 7634339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
    Xia G; Truitt RL; Johnson BD
    Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response.
    Jones SC; Murphy GF; Korngold R
    Biol Blood Marrow Transplant; 2003 Apr; 9(4):243-56. PubMed ID: 12720217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of naturally arising regulatory T cells in hematopoietic cell transplantation.
    Nguyen VH; Zeiser R; Negrin RS
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):995-1009. PubMed ID: 17084366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural suppressor (NS) activity from murine neonatal spleen is responsive to IFN-gamma.
    Maier T; Holda JH
    J Immunol; 1987 Jun; 138(12):4075-84. PubMed ID: 2953798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of graft-versus-host disease by a novel immunosuppressant, (5R)-5-hydroxytriptolide (LLDT-8), through expansion of regulatory T cells.
    Tang W; Yang Y; Zhang F; Li YC; Zhou R; Wang JX; Zhu YN; Li XY; Yang YF; Zuo JP
    Int Immunopharmacol; 2005 Dec; 5(13-14):1904-13. PubMed ID: 16275625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. II. Development of natural suppressor cell activity.
    Maier T; Holda JH; Claman HN
    J Immunol; 1985 Sep; 135(3):1644-51. PubMed ID: 3160774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of graft-versus-host disease by Fab fragments derived from ALG.
    Richie ER; Gallagher MT; Trentin JJ
    Transplant Proc; 1973 Mar; 5(1):873-6. PubMed ID: 4144467
    [No Abstract]   [Full Text] [Related]  

  • 12. Analysis of murine T lymphocyte markers during the early phases of GvH-associated suppression of cytotoxic T lymphocyte responses.
    Hurtenbach U; Shearer GM
    J Immunol; 1983 Apr; 130(4):1561-6. PubMed ID: 6220057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of protection from graft-vs-host disease in murine mixed allogeneic chimeras. I. Development of a null cell population suppressive of cell-mediated lympholysis responses and derived from the syngeneic bone marrow component.
    Sykes M; Eisenthal A; Sachs DH
    J Immunol; 1988 May; 140(9):2903-11. PubMed ID: 2966200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous protection against allograft rejection and graft-versus-host disease after total lymphoid irradiation: role of natural killer T cells.
    Liu YP; Li Z; Nador RG; Strober S
    Transplantation; 2008 Feb; 85(4):607-14. PubMed ID: 18347541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depletion of asialo-GM1+ cells from the F1 recipient mice prior to irradiation and transfusion of parental spleen cells prevents mortality to acute graft-versus-host disease and induction of anti-host specific cytotoxic T cells.
    Varkila K
    Clin Exp Immunol; 1987 Sep; 69(3):652-9. PubMed ID: 3499271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of acute graft-versus-host disease and chimerism after adoptive transfer of in vitro-expanded invariant Valpha14 natural killer T cells.
    Kuwatani M; Ikarashi Y; Iizuka A; Kawakami C; Quinn G; Heike Y; Yoshida M; Asaka M; Takaue Y; Wakasugi H
    Immunol Lett; 2006 Jul; 106(1):82-90. PubMed ID: 16806496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of natural suppressor cells in bone marrow transplantation.
    Strober S; Hertel-Wulff B; Schwadron RB
    Transplant Proc; 1987 Dec; 19(6 Suppl 7):88-94. PubMed ID: 2962358
    [No Abstract]   [Full Text] [Related]  

  • 18. [Suppressors of the graft vs graft reaction in tolerance to alloantigens].
    Cherniakhovskaia IIu; Prigozhina TB; Nagurskaia EV; Fontalin LN
    Biull Eksp Biol Med; 1988 Jun; 105(6):697-700. PubMed ID: 2968819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia.
    Trenado A; Charlotte F; Fisson S; Yagello M; Klatzmann D; Salomon BL; Cohen JL
    J Clin Invest; 2003 Dec; 112(11):1688-96. PubMed ID: 14660744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming T cell-mediated rejection of bone marrow allografts by T-regulatory cells: synergism with veto cells and rapamycin.
    Steiner D; Brunicki N; Bachar-Lustig E; Taylor PA; Blazar BR; Reisner Y
    Exp Hematol; 2006 Jun; 34(6):802-8. PubMed ID: 16728286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.